Arrowhead Pharmaceuticals Inc. | Mid-cap | Healthcare
$16.84
0.30%
| Arrowhead Stock Comparison:
Arrowhead vs VertexArrowhead vs RegeneronArrowhead vs Blueprint MedicinesArrowhead vs Roivant SciencesArrowhead vs Bio-TechneArrowhead vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 3.6M
Operating Income -601.1M -16,927.06%
Net Income -609.7M -17,169.61%
EPS (Diluted) -$5.00

Balance Sheet Metrics

Total Assets 1.1B
Total Liabilities 948.7M
Shareholders Equity 191.1M
Debt to Equity 4.97

Cash Flow Metrics

Operating Cash Flow -490.1M
Free Cash Flow -604.3M

Revenue & Profitability Trend

Arrowhead Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue3.6M240.7M243.2M138.3M88.0M
Cost of Goods Sold-----
Gross Profit-----
Operating Expenses602.7M444.1M421.7M287.3M181.2M
Operating Income-601.1M-205.0M-178.5M-149.0M-93.2M
Pre-tax Income-612.5M-206.5M-172.7M-140.8M-84.6M
Income Tax-2.8M2.8M3.8M2.0K2.0K
Net Income-609.7M-209.3M-176.5M-140.8M-84.6M
EPS (Diluted)-$5.00-$1.92-$1.67-$1.36-$0.84

Income Statement Trend

Arrowhead Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets695.5M416.5M405.3M384.6M322.4M
Non-Current Assets444.3M349.1M286.6M325.6M200.1M
Total Assets1.1B765.6M691.9M710.1M522.5M
Liabilities
Current Liabilities103.2M105.5M138.8M146.5M40.7M
Non-Current Liabilities845.6M372.9M134.8M154.8M20.0M
Total Liabilities948.7M478.4M273.6M301.3M60.7M
Equity
Total Shareholders Equity191.1M287.2M418.3M408.8M461.8M

Balance Sheet Composition

Arrowhead Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-609.7M-209.3M-176.5M-140.8M-84.6M
Operating Cash Flow-490.1M-148.5M-139.0M163.9M-97.4M
Investing Activities
Capital Expenditures-141.5M-176.7M-52.8M-23.6M-12.0M
Investing Cash Flow-420.1M-96.2M-5.4M-141.7M-240.8M
Financing Activities
Dividends Paid-----
Financing Cash Flow868.1M250.0M60.0M0250.5M
Free Cash Flow-604.3M-330.6M-188.9M147.7M-107.8M

Cash Flow Trend

Arrowhead Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -3.12
Forward P/E -3.63
Price to Book 3.10
Price to Sales 3.88
PEG Ratio -3.63

Profitability Ratios

Profit Margin -26.41%
Operating Margin 70.24%
Return on Equity -26.22%
Return on Assets -5.86%

Financial Health

Current Ratio 5.15
Debt to Equity 108.23
Beta 0.95

Per Share Data

EPS (TTM) -$1.24
Book Value per Share $4.95
Revenue per Share $4.31

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
arwr2.1B-3.123.10-26.22%-26.41%108.23
Vertex 114.1B32.826.92-5.64%-8.91%10.00
Regeneron 55.3B13.021.8415.96%31.94%9.20
Blueprint Medicines 8.3B-120.0024.19-47.71%-27.70%208.50
Roivant Sciences 7.8B1.951.71-12.54%96.86%1.93
Bio-Techne 7.9B60.873.926.53%10.89%20.99

Financial data is updated regularly. All figures are in the company's reporting currency.